Minimizing Cardiotoxicity While Optimizing Treatment Efficacy with Trastuzumab: Review and Expert Recommendations-Reference-Cited by-同舟云学术

Minimizing Cardiotoxicity While Optimizing Treatment Efficacy with Trastuzumab: Review and Expert Recommendations

Published:2009-01-01 Issue:1 Volume:14 Page:1-11
ISSN:1083-7159
Container-title:The Oncologist
language:en
Short-container-title:

Author:

Martín Miguel¹,Esteva Francisco J.²,Alba Emilio³,Khandheria Bijoy⁴,Pérez-Isla Leopoldo⁵,García-Sáenz José Ángel¹,Márquez Antonia³,Sengupta Partho⁴,Zamorano José⁵

Affiliation:

1. a Department of Medical Oncology, San Carlos University Hospital, Madrid, Spain

2. b MD Anderson Cancer Center, Houston, Texas, USA

3. c Department of Oncology, Vírgen de la Victoria University Hospital, Málaga, Spain

4. d Department of Cardiovascular Diseases, Mayo Clinic, Scottsdale, Arizona, USA

5. e Department of Cardiology, San Carlos University Hospital, Madrid, Spain

Abstract

Learning Objectives Analyze the clinical trial data for the treatment of breast cancer. Evaluate the risk of cardiotoxicity associated with the use of trastuzumab. Design and conduct a practical approach to managing patients with trastuzumab-associated cardiotoxicity. This article is available for continuing medical education credit at CME.TheOncologist.com.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1634/theoncologist.2008-0137

Reference56 articles.

1. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene;Slamon;Science,1987

2. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer;Slamon;Science,1989

3. Basic science of HER-2/neu: A review;Hung;Semin Oncol,1999

4. Humanization of an anti-p185HER2 antibody for human cancer therapy;Carter;Proc Natl Acad Sci U S A,1992

5. Nonclinical studies addressing the mechanism of action of trastuzumab (Herceptin);Sliwkowski;Semin Oncol,1999

Cited by 126 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating Cardiovascular Biomarkers in Cancer Therapeutics‐Related Cardiotoxicity: Review of Critical Challenges, Solutions, and Future Directions;Journal of the American Heart Association;2023-11-07

2. Doxorubicin-induced modulation of TGF-β signaling cascade in mouse fibroblasts: insights into cardiotoxicity mechanisms;Scientific Reports;2023-11-02

3. Doxorubicin-Induced Modulation of TGF-β Signaling Cascade in Mouse Fibroblasts: Insights into Cardiotoxicity Mechanisms;2023-07-27

4. Diastolic heart failure is a new clinical entity of trastuzumab-induced cardiotoxicity: a case report;European Heart Journal - Case Reports;2022-12-08

5. Optimizing combination therapy in a murine model of HER2+ breast cancer;Computer Methods in Applied Mechanics and Engineering;2022-12